FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Ho Henry Chi Fung

2. Date of Event Requiring Statement (MM/DD/YYYY)
11/15/2010 

3. Issuer Name and Ticker or Trading Symbol

CHINA MEDICINE CORP [CHME.OB]

(Last)        (First)        (Middle)

2/F, GUANGRI TOWER, NO. 9 SIYOUNAN ROAD 1ST STREET,

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Chief Financial Officer /

(Street)

YUEXIU DISTRICT, GUANGZHOU, F4 510600       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   (1) 120000   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
( 1)  These are shares of restricted stock granted as a portion of Mr. Ho's compensation, and will vest in accordance with the following schedule: (a) as to 24,000 shares (20%) on October 2, 2011, (b) as to an additional 24,000 shares (20%) on October 2, 2012, (c) as to an additional 36,000 shares (30%) on October 2, 2013, and (d) as to the final 36,000 shares (30%) on October 2, 2014, so as to be 100% vested on October 2, 2014, contingent upon Mr. Ho's continued employment with the Company as of each vesting date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Ho Henry Chi Fung
2/F, GUANGRI TOWER
NO. 9 SIYOUNAN ROAD 1ST STREET,
YUEXIU DISTRICT, GUANGZHOU, F4 510600

Chief Financial Officer

Signatures
/s/ Henry Chi Fung Ho 11/24/2010
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
China Medicine (CE) (USOTC:CHME)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas China Medicine (CE).
China Medicine (CE) (USOTC:CHME)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas China Medicine (CE).